Ternium S.A. (TX) News
Follow Ternium S.A. (TX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 20 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Tenaris Announces 2026 Third-Quarter Results
Tenaris announced its third-quarter 2026 results. The available text says the financial and operational information is unaudited.
EQUITY | Nov 04, 2026, 09:30 PM UTC
M
Ternium Q3 2026 Call Reports EBITDA, Dividend and Market Updates
Ternium reported Q3 EBITDA of $785 million, up 10% sequentially, and declared an interim dividend of $0.90 per ADS. Management said Q4 EBITDA is expected to remain broadly in line with Q3; the transcript also covered reg
EQUITY | Nov 04, 2026, 02:15 PM UTC
M
TX Reports Fiscal Q3 Attributable Profit Up 175.91%
TX reported attributable profit of 8.36亿美元 for fiscal Q3 2026, up 175.91% year over year.
EQUITY | Nov 04, 2026, 06:42 AM UTC
M
Ternium Swings to Third-Quarter Profit
EARNINGS | Nov 03, 2026, 10:06 PM UTC
M
Ternium Adjusted EBITDA Rises 87% in Q3 2026
Ternium’s adjusted EBITDA rose 87% year over year in the third quarter of 2026.
EARNINGS | Nov 03, 2026, 09:42 PM UTC
M
Ternium Turns Profitable in Third Quarter
Ternium reported net profit in the third quarter, compared with a loss a year earlier. Net sales were higher year over year, but the amount is not provided.
EARNINGS | Nov 03, 2026, 09:41 PM UTC
M
Ternium Reports Q3 Revenue of $4.64B
Ternium reported third-quarter revenue of $4.64 billion, versus a FactSet estimate of $4.65 billion.
EQUITY | Nov 03, 2026, 09:22 PM UTC
M
Ternium Reports Q3 Earnings of $1.42 per ADS
Ternium reported Q3 earnings of $1.42 per ADS, versus the FactSet estimate of $1.83.
EQUITY | Nov 03, 2026, 09:21 PM UTC
M
Ternium Reports Third-Quarter Adjusted EBITDA of $785M
Unaudited third-quarter 2026 adjusted EBITDA was $785M, up 10% sequentially. Net income was $368M after a $116M deferred tax loss; the board approved an interim dividend of $0.90 per ADS.
EARNINGS | Nov 03, 2026, 09:17 PM UTC
M
Ternium Announces Third-Quarter and Nine-Month 2026 Results
Ternium announced results for the third quarter and first nine months ended September 30, 2026.
EQUITY | Nov 03, 2026, 09:17 PM UTC
L
JP Morgan raises Ternium price target to $67.50
JP Morgan raised its Ternium price target to $67.50 per share from $60.50 and maintained an Overweight rating, per Benzinga (TradingView News).
EQUITY | Sep 04, 2026, 12:28 PM UTC
L
Ternium Is Maintained at Neutral by UBS
Ternium Is Maintained at Neutral by UBS
EQUITY | Aug 27, 2026, 02:51 PM UTC
L
HSBC downgrades TX to Hold, raises target to $55
HSBC downgrades TX to Hold from Buy and raises its price target to $55 from $53.
EQUITY | Aug 21, 2026, 11:58 AM UTC
M
Morgan Stanley raises TX to Overweight, lifts target to $65
Morgan Stanley upgrades TX to Overweight from Equalweight and raises its price target to $65 from $55.
EQUITY | Aug 21, 2026, 11:58 AM UTC
M
TX downgraded to Hold at HSBC, price target raised to $55
HSBC downgrades TX to Hold from Buy and raises its price target to $55 from $53.
EQUITY | Aug 21, 2026, 11:18 AM UTC
L
TX upgraded to Overweight at Morgan Stanley, price target raised to $65
Morgan Stanley upgrades TX from Equal Weight to Overweight and raises its price target to $65 from $55.
EQUITY | Aug 21, 2026, 11:13 AM UTC
L
TX - Ternium Announces Second Quarter and First Half of 2026 Results
TX - Ternium Announces Second Quarter and First Half of 2026 Results
EQUITY | Aug 04, 2026, 08:15 PM UTC
L
[Latest] Global Beadlets Capsule Market Size/Share Worth USD 968.45 Million by 2035 at a 6.85% CAGR: Healthcare Foresights (Analysis, Outloo
Austin, TX, USA, July 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a
FX | Jul 06, 2026, 04:30 AM UTC
L
OlloBot to Launch Ollo-Family Plush IP Blind Boxes at Houston Pop-Up This July
HOUSTON, TX, July 03, 2026 (GLOBE NEWSWIRE) -
EQUITY | Jul 03, 2026, 11:13 AM UTC
L
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Out
Austin, TX, USA, July 03, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a
FX | Jul 03, 2026, 08:30 AM UTC
L
[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlo
Austin, TX, USA, July 03, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a
FX | Jul 03, 2026, 04:30 AM UTC